Sign up to save your podcasts
Or
Share Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
129 Listeners
Global News Podcast
7,904 Listeners
Neurology® Podcast
273 Listeners
NEJM This Week
313 Listeners
Practical Neurology Podcast
35 Listeners
JAMA Clinical Reviews
488 Listeners
JAMA Neurology Author Interviews
13 Listeners
Annals On Call Podcast
169 Listeners
The Clinical Problem Solvers
506 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
317 Listeners
Neurology Exam Prep Podcast
176 Listeners
The Curious Clinicians
365 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
75 Listeners